>>> US Gapping up

Gapping up
In reaction to earnings/guidance
:

  • OXM +9.1%, RH +8%, SIG +7.6%, GEF +2.1%, CANO +1.4%, PNR +1.2%

Other news:

  • VRNA +16.4% (Verona Pharma and Nuance Pharma announce $219 mln strategic collaboration to develop and commercialize Ensifentrine in greater China)
  • BTBT +3.9% (announces strategic collaboration with digihost to increase combined hashrates by 400 PH/S)
  • ACRS +3.7% (prices offering of 7,042,254 shares of its common stock at $17.75 per share)
  • ARAY +3.7% (expands commercialization of ClearRT helical fan-beam kVCT imaging for the Radixact system with CE mark certification)
  • TLYS +3.4% (delares $1.00/sh special dividend)
  • LTRX +3.1% (expanded relationship with Insight Enterprises (NSIT), now offering full range of products)
  • NOA +2.5% (to acquire DGI Trading Pty)
  • CASI +1.8% (prices offering of $150.0 million of convertible senior notes due 2026)
  • COIN +1.8% (partnering with ForUsAll, a 401(k) provider to offer cryptocurrency, according to WSJ)
  • OBSV +1.7% (reports PROLONG Phase 2a Proof-of-Concept Data on Ebopiprant)
  • HYFM +1.6% (stock offering)
  • LESL +1.5% (prices offering of 24.5 mln shares of common stock at $27.64 per share)
  • AB +1.4% (reports May AUM)
  • APR +1.3% (prices secondary offering of 4.5 mln shares of common stock at $27.00 per share)
  • EARN +1.1% (raises quarterly dividend by 7% to $0.30 per share)
  • DM +1% (receives CE Mark Certification and international launch for Flexcera Next Generation 3D printed dentures)

Analyst comments:

  • CYH +4.8% (upgraded to Outperform from Sector Perform at RBC Capital Mkts)
  • IOVA +4.5% (upgraded to Mkt Outperform from Mkt Perform at JMP Securities)
  • PUBM +3.2% (upgraded to Outperform from In-line at Evercore ISI)
  • NOW +2.9% ( upgraded to Conviction Buy from Buy at Goldman)
  • BSMX +2.4% (upgraded to Buy from Hold at HSBC Securities)
  • PNTG +2.3% (upgraded to Outperform from Sector Perform at RBC Capital Mkts)
  • CPG +1.8% (upgraded to Outperform from Sector Perform at RBC Capital Mkts)
  • FFIV +1.7% (upgraded to Outperform from Neutral at Credit Suisse)
  • UPS +1.6% (upgraded to Overweight from Neutral at JP Morgan)
  • DNB +1.5% (upgraded to Outperform from Mkt Perform at Raymond James)
  • MRO +1.3% (upgraded to Outperform from Sector Perform at RBC Capital Mkts)